2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T25593 | Labetuzumab govitecan | IMMU-130,Labetuzumab-SN38,hMN14-SN38,IMMU130,IMMU 130 | Others |
Labetuzumab govitecan is an anti-CEACAM5/SN-38 antibody-drug conjugate for therapy of refractory or relapsing metastatic colorectal cancer. | |||
T17732 | CL2A | Others | |
CL2A is a pH-sensitive, cleavable PEG8- and triazole-containing PABC-peptide-mc linker, characterized by its ability to induce a bystander effect. It forms a disulfide bond with an antibody at a cysteine residue. Labetuz... |